Roche’s tocilizumab cuts deaths in hospitalised COVID-19 patients – study – Reuters
Roche’s arthritis drug tocilizumab cuts the risk of death among patients hospitalised with severe COVID-19, also shortening the time to recovery and reducing the need for mechanical ventilation, results of a large trial showed on Thursday.
